Curcumin improves early functional results after experimental spinal cord injury

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Curcumin, a polyphenol from Curcuma longa, possesses known anti-oxidative, anticancerous, and anti-inflammatory properties.
• Spinal cord injury (SCI) is a debilitating condition requiring effective therapeutic interventions.

Purpose of the Study:

• To compare the efficacy of curcumin and methylprednisolone sodium succinate (MPSS) in an experimental rat model of SCI.
• To evaluate the functional, biochemical, and pathological effects of curcumin and MPSS post-SCI.

Main Methods:

• Forty rats were divided into five groups: laminectomy control, SCI, SCI + MPSS, SCI + curcumin, and SCI + vehicle.
• Functional recovery was assessed using the inclined plane and Basso-Beattie-Bresnahan scales.
• Biochemical analysis included malondialdehyde (MDA), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and catalase (CAT) activity.
• Pathological evaluation of spinal cord tissue was performed using light microscopy.

Main Results:

• Curcumin treatment significantly improved neurological outcomes compared to the control and vehicle groups.
• Biochemical analysis revealed decreased MDA levels and increased GSH-Px, SOD, and CAT activity in the curcumin group.
• Histopathological examination showed preserved spinal cord tissue structure in rats treated with curcumin.

Conclusions:

• Curcumin exhibits significant neuroprotective effects in an experimental SCI model.
• The mechanism involves enhancing endogenous antioxidant systems (GSH-Px, SOD, CAT), reducing oxidative stress, and preserving tissue integrity.
• Curcumin holds potential as a therapeutic agent for promoting neuronal survival after spinal cord injury.